Minister Beke belooft extra middelen voor mensen op de wachtlijst. Lees hier wat hierover (en over andere urgente kwesties uit onze sector) in de media is verschenen.
In de pers - juni 2021
Over de wachtlijsten
• 30/06/2021 De mededeling dat Minister van Welzijn Wouter Beke (CD&V) inspanningen doet om het budget voor de gehandicaptenzorg sneller vrij te maken èn te verhogen, wordt op gemengde gevoelens onthaald. Op vrt.nws lees je meer.
• 30/06/2021 Er wordt van overheidswege eindelijk gecommuniceerd: de wachttijd voor mensen met een handicap in Prioriteitengroep 1 wordt teruggebracht tot 18 maanden en de minister belooft extra middelen. Lees hier meer (vrt-nieuws).
• 25/06/2021 Mensenrechtenorganisatie GRIP en een groep personen met een handicap leggen op maandag 28 juni samen met advocaten van Progress Lawyers Network een verzoekschrift neer bij de Raad van State. Ze vragen de nietigverklaring van de ‘actualisering’ van persoonsvolgende budgetten (PVB), een Vlaams besluit dat voor de zoveelste keer de levens van meer dan 10.000 mensen met een beperking treft. Lees hier het opiniestuk van Lynn Formesyn, beleidsmedewerker van GRIP (let wel: het zit achter een betaalmuur).
• 16/06/2021 Een tiental organisaties, waartoe ook STAN behoort, organiseert een actie op sociale media onder de noemer #genoeggewacht waarin ze de Vlaamse regering oproepen om de 20.000 mensen op de wachtlijst niet in de kou te laten staan. Je vindt hier de link naar onze Facebookpagina.
• 10/06/2021 De Standaard publiceert een artikel over de stijgende cijfers op de wachtlijsten. Lees hier het artikel.
• 10/06/2021 Terzake wijdt een item aan het zorgbudget en de wachtlijsten. Joke Mariman (die samen met 1802 op de wachtlijst Prior 1 staat) en Eddy Schelfhout (samen met meer dan 11000 mensen op Prior 3) getuigen over het totale gebrek aan perspectief. Bekijk hier de reportage.
• 09/06/2021 Ondanks extra budget blijven de wachtlijsten voor mensen met een beperking stijgen. Dat blijkt uit het jaarverslag van het VAPH dat je hier kan lezen.
• 09/06/2021 Mensenrechtenorganisatie GRIP wil samen met Progress Lawyers Network naar de Raad van State trekken omdat de Vlaamse Regering de rechten schendt van een groep mensen met een handicap op de wachtlijst voor een Persoonsvolgend Budget (PVB). Lees hier het artikel in De Wereld Morgen.
• 03/06/2021 De Panoreportage 'Wachten op zorg' die journaliste Goedele Devroy vorig jaar maakte, wint een belangrijke persprijs. Lees hier meer.
• 01/06/2021 Een tiental middenveldorganisatie waartoe ook STAN behoort, schrijven een gezamenlijk persbericht waarin ze het gebrek aan een toekomstplan inzake de wachtlijsten en de beloofde budgetten aankaarten. Lees hier het artikel in het Nieuwsblad.
• Lees ook de analyse en de aanbevelingen hierover in het opiniestuk van STAN-coördinator Dries Fonteyn op onze website.
Over het buitengewoon onderwijs
• 16/06/2021 In het programma 'De Ochtend' getuigt een leerkracht uit het reguliere onderwijs dat ze kinderen in haar klas heeft die het moeilijk hebben, maar voor wie geen plaats meer is in het buitengewoon onderwijs. "We doen ons best om deze kinderen te helpen, maar soms is dat niet mogelijk" zegt ze. Beluister hier het interview.
• 15/06/2021 Terzake bericht over het 'Nijpend plaatsgebrek in het buitengewoon onderwijs'. Lees en herbekijk de uitzending hier.
• 10/06/2021 Thuisbegeleidingsdienst Kadodder illustreert het schrijnend tekort aan plaatsen in het buitengewoon onderwijs met concrete cijfers. Je kan hun open brief downloaden via deze link.
• 08/06/2021 De Gentse vzw Konekt wil met de campagne #tismaarda bedrijven over de streep trekken om ook mensen met een verstandelijke beperking aan te werven. Hier lees je er meer over.
• 03/06/2021 Geen plaats meer in het buitengewoon onderwijs. Het filmpje waarin een moeder de problematiek schetst, gaat viraal. Lees hier het artikel uit het Nieuwsblad (en bekijk het filmpje).
Over het inzetten van mensen met een verstandelijke handicap op de arbeidsmarkt
• 03/06/2021 Frederik Wauterickx is eerste werknemer met Down op de reguliere arbeidsmarkt. Lees hier het artikel uit Trends.
En verder...
• 10/06/2021 Tijdschrift rekto:verso wijdt een themanummer over beperking in de kunstwereld en over 'validisme' (oftewel de structurele uitsluiting van mensen met een handicap) in de kunsten. Het nummer werd gecureerd door vier gastredacteurs. Lees meer hier.
• 09/06/2021 Onze G-judoclubs de Buitelaars van STAN Gent-Eeklo en de Juniors van STAN Antwerpen feliciteren wereldkampioen Matthias Casse die zich wereldkampioen judo mag noemen. Lees hier meer.
• 08/06/2021 Op sociaal.net verschijnt een mooi en warm relaas van hoe men in Italië omgaat met mensen die anders zijn of zich vreemd gedragen. Lees de column hier.
• 03/06/2021 Het reclamefilmpje #AllDreamsAreEqual voor de Special Olympics (2020), waarin STAN-lid Alice de hoofdrol speelt, werd bekroond met een zilveren CCB-Award ('Creative Club of Belgium'- award, dat zijn de prijzen die de mensen uit de publiciteitswereld jaarlijks uitreiken). Bekijk het filmpje hier.
Reacties
-
Anavar‑Only Cycle – 4‑Week Results with Before/After Pics
Anavar, also known as oxandrolone, is one of the most popular anabolic steroids for those
looking to achieve subtle but noticeable improvements in muscle definition without significant water retention or drastic bulking.
Many users opt for a short four‑week cycle because it allows them to experience the benefits while minimizing potential side effects and making it
easier to track progress. A typical four‑week Anavar cycle involves taking 20–40 mg per day,
often split into two doses (morning and evening) to maintain stable blood
levels. Throughout the cycle, users may incorporate a post‑cycle therapy (PCT) if they plan to extend usage beyond a few weeks,
but for pure results tracking, the focus is on what can be achieved during
those 28 days alone.Typical Results After Four Weeks
Muscle Gain
During a four‑week Anavar cycle, many people see an average increase of 1–2 kg (2–4 lb) in lean body
mass. Because Anavar has low androgenic activity and is relatively
mild compared to other steroids, the muscle gains tend to be more about quality than quantity.
Users report tighter, firmer muscles with improved tone, especially around
the chest, arms, shoulders, and core. The effect is most pronounced when combined with a
high‑protein diet (1.5–2 g protein per kilogram of body weight) and a well‑structured resistance training program that emphasizes
progressive overload.Fat Loss
One of Anavar’s hallmark benefits is its ability to promote fat loss while
preserving muscle mass. After four weeks, many
users notice a reduction in abdominal circumference and a clearer definition of abdominal muscles.
The average rate of fat loss reported ranges from 0.5–1 kg (1–2 lb) per week if the caloric deficit is maintained
at around 500 calories below maintenance.This translates into an overall loss of 2–4 kg
(4–9 lb) over the course, which can dramatically improve body composition.Strength Gains
Strength improvements are another key indicator of success on Anavar.
Typical increases in bench press and squat strength range from 5–10 % compared to pre‑cycle levels.
For example, a lifter who could bench press
80 kg before starting may be able to push 85–90 kg after four weeks.
This boost is largely due to enhanced protein synthesis and
faster recovery times, allowing athletes to train harder and more frequently.Recovery
Users often report significantly reduced muscle soreness
and quicker recovery between sessions. This is partly because Anavar helps
maintain nitrogen balance in the body, which facilitates tissue repair.Consequently, many individuals can increase training volume without
experiencing the same level of fatigue that would normally accompany
a longer steroid cycle.Visual Evidence: Anavar Only Cycle Results Pictures
Although I cannot provide images directly here, there are
numerous reputable bodybuilding forums and social media platforms where users post before‑and‑after photos from their four‑week Anavar cycles.
These pictures typically show:Chest and Shoulder Definition – The pectoral muscles look more sculpted, with clearer
separation between the upper chest and shoulder area.Arms – Biceps and triceps appear thicker and less bloated, giving a cleaner, more muscular look.
Core – Abdominal muscles become visibly defined;
the six‑pack or eight‑pack is often more pronounced due to reduced subcutaneous fat.Legs – Quads and hamstrings show improved tone, especially around the knee joint
where muscle fibers are more distinct.Users usually document their progress by taking photos at consistent lighting and
angles each week. This practice allows for objective comparison and helps highlight incremental changes that
might otherwise be missed in daily observation.
When reviewing such pictures, it is essential to note that individual results
vary based on genetics, diet, training intensity, and adherence to the cycle protocol.Factors Influencing Individual Outcomes
Diet: A high‑protein intake paired with a moderate caloric deficit or maintenance
level is critical for maximizing muscle retention while shedding fat.
Skipping protein or eating too many calories can blunt Anavar’s benefits.Training: Resistance training that focuses on compound lifts (bench press, squat,
deadlift) combined with isolation work enhances the anabolic stimulus.
Overtraining without adequate rest, however, may negate some of the
recovery advantages.Lifestyle: Adequate sleep (7–9 hours per night) and stress
management play roles in hormone regulation, which can affect how well Anavar is metabolized and how effectively muscle protein synthesis occurs.Dosage: Sticking to a conservative dose (20–30 mg/day) reduces the risk of
side effects such as mild estrogenic conversion or liver strain while
still delivering measurable results. Higher doses can increase gains but also elevate the likelihood of adverse reactions.Common Side Effects and Management
Because Anavar is relatively mild, serious side effects
are uncommon in a short cycle, yet some users may experience:Hair loss – Especially in genetically predisposed individuals; topical minoxidil or finasteride can help
mitigate this.Mood swings – A small number of users report irritability or anxiety; maintaining a
balanced diet and ensuring proper sleep helps.Liver stress – Though less hepatotoxic than other oral steroids,
using a reputable brand and limiting dosage reduces risk.Monitoring liver enzymes before and after the cycle
can provide peace of mind. If any symptoms arise, discontinuing
usage immediately is advisable.Post‑Cycle Therapy (PCT) Considerations
For individuals who decide to extend beyond four weeks or combine Anavar with other compounds, initiating PCT is recommended
to restore natural testosterone production. Common agents include clomiphene
citrate or tamoxifen, typically started 2–3 days after the
last dose of Anavar. A typical PCT protocol might involve:Clomiphene: 25 mg daily for two weeks.
Tamoxifen: 20 mg daily for two weeks.
These medications help counteract the suppression of the hypothalamic‑pituitary‑gonadal axis caused by steroid use,
ensuring a smoother transition back to normal hormonal levels.Summary
A four‑week Anavar cycle is an effective strategy for
athletes and bodybuilders seeking quick improvements in muscle definition, fat loss,
and strength without committing to a long-term steroid regimen. Results are typically visible
within the first two weeks, with notable gains by week four:
lean muscle mass increases by 1–2 kg, abdominal circumference shrinks, and training performance improves
by 5–10 %. Visual documentation from users shows clear
enhancements across the chest, arms, core, and legs.Success hinges on proper dosing, a protein‑rich diet, disciplined resistance training, and adequate recovery.
While side effects are generally mild, users should
remain vigilant and consider post‑cycle therapy if they plan to extend usage
or combine with other substances. -
Incredible points. Outstanding arguments. Keep up the great spirit.
-
I have read so many posts concerning the blogger lovers except this article is
actually a good post, keep it up. -
liver pills bodybuilding
-
what is the purpose of steroids
-
Excellent blog here! Also your website loads up very fast!
What host are you using? Can I get your affiliate link to your host?
I wish my site loaded up as quickly as yours lol -
where can i purchase steroids
-
what happens when you take steroids
-
naps steroids
-
Ipamorelin is a synthetic peptide that stimulates the release of growth hormone from the
pituitary gland. Although it is not specifically approved for any medical condition in women, some individuals
use it as part of anti‑aging or athletic regimens.
As with any hormonal agent, the potential side effects
can vary and may be influenced by underlying health conditions, dosage, route of administration, and individual sensitivity.
Below is a comprehensive guide focusing on side effect considerations relevant to women, with particular emphasis
on gastrointestinal symptoms such as nausea and vomiting, as well as how
general health status can modulate risk.A Guide to GLP‑1 Side Effects: What to Expect and How to Manage Them
Glucagon‑like peptide 1 (GLP‑1) analogs share some pharmacodynamic similarities with
ipamorelin, particularly in their influence on the hypothalamic–pituitary axis.
While ipamorelin is a growth hormone secretagogue rather than a GLP‑1 receptor
agonist, women who are simultaneously using GLP‑1 therapies (for example, for type 2
diabetes) may experience overlapping side effect profiles.
Common GLP‑1 related symptoms include gastrointestinal upset,
nausea, vomiting, and abdominal pain. Women should
monitor these effects closely because they can impact adherence to both treatments.Management strategies that apply to both ipamorelin and GLP‑1 agents are:
Dose Titration – Starting with the lowest
effective dose and gradually increasing can reduce peak serum concentrations that
trigger nausea or vomiting.Timing of Administration – Administering the peptide before meals may blunt post‑prandial gastrointestinal
responses.Hydration and Electrolyte Balance – Adequate fluid intake
helps mitigate dehydration from vomiting; electrolyte monitoring is advised if symptoms
persist.Dietary Adjustments – Consuming bland, low‑fat
foods can ease gastric irritation. Avoiding alcohol and caffeine reduces GI sensitivity.Adjunct Medications – Antiemetics such as ondansetron or metoclopramide may be prescribed
by a healthcare provider if nausea is severe.Nausea and Vomiting
In women using ipamorelin, nausea and vomiting are the most frequently
reported adverse events. The mechanisms involve transient alterations
in gut motility and central vestibular pathways.
Symptoms often appear within 30 minutes to an hour after injection or ingestion of
the peptide. Key points for recognizing and addressing
these symptoms include:Onset – Rapid onset following a dose,
especially when administered on an empty stomach.Severity Spectrum – Mild nausea may resolve spontaneously; persistent vomiting can lead to dehydration,
electrolyte imbalance, and discontinuation of therapy.Risk Factors – Prior history of motion sickness or gastrointestinal disorders heightens susceptibility.
Hormonal fluctuations during the menstrual cycle can also influence GI sensitivity.Management – Slow injection rate, use of a small gauge needle
for subcutaneous administration, and co‑administration with a proton pump inhibitor or H2 blocker may reduce gastric irritation.Women should keep a symptom diary to correlate specific doses or times
of day with nausea episodes. If vomiting occurs more than twice in a week, consultation with a healthcare professional is
recommended to adjust the regimen or explore alternative therapies.Health Conditions
Underlying health conditions can amplify ipamorelin’s side effect profile or necessitate caution. Important considerations include:
Cardiovascular Disease – Growth hormone can influence lipid metabolism and blood pressure.
Women with hypertension, coronary artery disease, or
heart failure should have their cardiovascular status monitored during
therapy.Endocrine Disorders – Conditions such as hypothyroidism, polycystic ovary syndrome (PCOS), or pituitary adenomas may
alter hormonal dynamics, potentially exacerbating side effects or diminishing efficacy.Regular thyroid function tests and reproductive hormone panels are advisable.
Gastrointestinal Disorders – Existing gastritis, irritable
bowel syndrome, or peptic ulcer disease increase the risk of nausea, vomiting, and abdominal pain. Pre‑treatment evaluation by a
gastroenterologist can help mitigate these risks.Renal Function – Although ipamorelin is primarily metabolized hepatically, severe renal impairment may alter
peptide clearance indirectly. Women with chronic
kidney disease should have renal function monitored and
dosage adjusted accordingly.Pregnancy and Lactation – There is insufficient safety data
for ipamorelin use during pregnancy or while breastfeeding.
Women who are pregnant or planning conception should avoid the peptide unless under close
medical supervision.In addition to these health conditions, lifestyle factors such as smoking,
alcohol consumption, and dietary habits influence how a woman tolerates ipamorelin. A holistic assessment that includes these variables allows for personalized dosing and reduces adverse events.Practical Take‑Away Points
Start with the lowest recommended dose and increase slowly while monitoring for nausea or vomiting.
Administer before meals and maintain adequate hydration to support gastrointestinal
tolerance.Keep an eye on any underlying health issues—cardiovascular, endocrine, renal, or
gastrointestinal—that could interact with growth hormone
release.Maintain a symptom log to capture timing, severity, and potential triggers of side effects.
Seek medical advice promptly if nausea persists beyond 48 hours,
if vomiting leads to dehydration, or if new symptoms such as chest pain or severe abdominal discomfort
arise.By approaching ipamorelin therapy with careful dose titration, vigilant
monitoring for gastrointestinal side effects, and consideration of individual
health status, women can reduce the likelihood of adverse events while potentially benefiting from
increased growth hormone secretion. -
strongest legal supplement for building muscle
-
purchase anabolic steroids